- Report
- March 2023
- 80 Pages
China
From €1323EUR$1,500USD£1,145GBP
From €1323EUR$1,500USD£1,145GBP
- Report
- November 2025
- 108 Pages
Philippines
From €2675EUR$3,248USD£2,396GBP
- Report
- October 2025
- 120 Pages
France
From €2675EUR$3,248USD£2,396GBP
- Report
- October 2025
- 25 Pages
France
From €995EUR$1,208USD£891GBP
- Report
- October 2025
- 81 Pages
Uruguay
From €2675EUR$3,248USD£2,396GBP
- Report
- October 2025
- 103 Pages
Netherlands
From €2675EUR$3,248USD£2,396GBP
- Report
- September 2025
- 50 Pages
Lebanon
From €2150EUR$2,610USD£1,926GBP
- Report
- September 2025
- 101 Pages
Argentina
From €2675EUR$3,248USD£2,396GBP
- Report
- April 2025
- 132 Pages
Global
From €4279EUR$4,850USD£3,703GBP
- Database
- July 2023
Global
From €318EUR$360USD£275GBP
- Report
- April 2023
- 65 Pages
India
- Report
- November 2022
- 76 Pages
Global
From €1765EUR$2,000USD£1,527GBP
- Report
- September 2022
- 54 Pages
Global
From €1765EUR$2,000USD£1,527GBP
- Report
- June 2022
- 53 Pages
Global
From €1765EUR$2,000USD£1,527GBP
- Report
- October 2023
- 91 Pages
Global
From €3500EUR$4,250USD£3,135GBP
- Report
- May 2022
- 78 Pages
Global
From €3500EUR$4,250USD£3,135GBP
- Report
- November 2025
- 84 Pages
Global
From €3500EUR$4,250USD£3,135GBP
- Report
- October 2024
- 90 Pages
Global
From €3500EUR$4,250USD£3,135GBP
- Report
- October 2024
- 96 Pages
Global
From €3500EUR$4,250USD£3,135GBP

The Antacid market is a segment of the Over the Counter (OTC) Drugs industry. Antacids are used to treat symptoms of acid reflux, heartburn, and indigestion. They are available in a variety of forms, including tablets, liquids, and chewable gummies. Antacids are generally safe and effective, and can be purchased without a prescription.
The Antacid market is highly competitive, with a wide range of products available from both large and small companies. Many of the products are marketed as being fast-acting and long-lasting, and some are formulated to provide additional benefits such as relief from gas and bloating.
Some of the companies in the Antacid market include GlaxoSmithKline, Pfizer, Bayer, Johnson & Johnson, Novartis, and Procter & Gamble. Show Less Read more